LGP.ASX: Proposed sale of WA production facility

Proposed sale of WA production facility

Stock	Little Green Pharma Ltd (LGP.ASX)
Release Time	19 Feb 2026, 9:30 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Little Green Pharma to sell WA production facility

Key Points

Signed agreement to sell and lease back production facility in Western Australia
Sale proceeds to fund opportunities in Australia and expansion into Europe
Will continue to operate the facility under a head lease for ~3.5 years

Full Summary

Little Green Pharma Ltd (ASX:LGP) has signed an agreement to sell and lease back its production facility in South-West Western Australia. The facility comprises a ~1.3tpa GACP indoor cultivation facility and GMP-compliant production facility. The sale price is $7.8 million, and the buyer is Lauana Pty Ltd ATF Lauana Trust. The parties are now working to satisfy the various conditions precedent to the contract, which include buyer due diligence, financing, and agreement of a head lease through to 29 August 2029. LGP will continue to operate the facility under the head lease for a further period of approximately 3.5 years. As per the company's strategy, the sale proceeds will be used to fund opportunities in Australia and expansion into growth markets in Europe.